erythrosine has been researched along with rifamycin sv in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Courtois, A; de Vries, EG; Fardel, O; Guillouzo, A; Payen, L; Vernhet, L | 1 |
Akita, H; Hayashi, H; Hofmann, AF; Mita, S; Onuki, R; Sugiyama, Y; Suzuki, H | 1 |
2 other study(ies) available for erythrosine and rifamycin sv
Article | Year |
---|---|
Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells.
Topics: Antibiotics, Antitubercular; ATP-Binding Cassette Transporters; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Fluoresceins; Humans; Lung Neoplasms; Models, Chemical; Multidrug Resistance-Associated Proteins; Rifampin; Rifamycins; Tumor Cells, Cultured | 1999 |
Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Biological Transport; Cholestasis; Cyclosporine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoresceins; Kinetics; LLC-PK1 Cells; Organic Anion Transporters, Sodium-Dependent; Oxadiazoles; Rifampin; Rifamycins; Swine; Symporters; Taurocholic Acid; Transfection | 2006 |